| Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response MJ Leckie, A ten Brinke, J Khan, Z Diamant, BJ O'connor, CM Walls, ... The Lancet 356 (9248), 2144-2148, 2000 | 2320 | 2000 |
| Age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction N Thevaranjan, A Puchta, C Schulz, A Naidoo, JC Szamosi, ... Cell host & microbe 21 (4), 455-466. e4, 2017 | 999 | 2017 |
| Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response SA Bryan, BJ O'Connor, S Matti, MJ Leckie, V Kanabar, J Khan, ... The Lancet 356 (9248), 2149-2153, 2000 | 563 | 2000 |
| The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort J Guzman, K Oen, LB Tucker, AM Huber, N Shiff, G Boire, R Scuccimarri, ... Annals of the rheumatic diseases 74 (10), 1854-1860, 2015 | 263 | 2015 |
| Treatment algorithms for systemic sclerosis according to experts A Fernández‐Codina, KM Walker, JE Pope, ... Arthritis & Rheumatology 70 (11), 1820-1828, 2018 | 216 | 2018 |
| Early mortality in a multinational systemic sclerosis inception cohort Y Hao, M Hudson, M Baron, P Carreira, W Stevens, C Rabusa, ... Arthritis & rheumatology 69 (5), 1067-1077, 2017 | 196 | 2017 |
| TNF drives monocyte dysfunction with age and results in impaired anti-pneumococcal immunity A Puchta, A Naidoo, CP Verschoor, D Loukov, N Thevaranjan, TS Mandur, ... PLoS pathogens 12 (1), e1005368, 2016 | 164 | 2016 |
| Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey SE Sattui, JW Liew, K Kennedy, E Sirotich, M Putman, TT Moni, A Akpabio, ... RMD open 7 (3), e001814, 2021 | 146 | 2021 |
| Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study C Rodd, B Lang, T Ramsay, N Alos, AM Huber, DA Cabral, R Scuccimarri, ... Arthritis care & research 64 (1), 122-131, 2012 | 145 | 2012 |
| Changes in exhaled carbon monoxide and nitric oxide levels following allergen challenge in patients with asthma P Paredi, MJ Leckie, I Horvath, L Allegra, SA Kharitonov, PJ Barnes European Respiratory Journal 13 (1), 48-52, 1999 | 129 | 1999 |
| Sputum T lymphocytes in asthma, COPD and healthy subjects have the phenotype of activated intraepithelial T cells (CD69+ CD103+) MJ Leckie, GR Jenkins, J Khan, SJ Smith, C Walker, PJ Barnes, ... Thorax 58 (1), 23-29, 2003 | 117 | 2003 |
| Anti-interleukin-5 monoclonal antibodies: preclinical and clinical evidence in asthma models MJ Leckie American Journal of Respiratory Medicine 2, 245-259, 2003 | 102 | 2003 |
| Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients MRJ Green, ASM Kennell, MJ Larche, MH Seifert, DA Isenberg, ... Clinical & Experimental Immunology 141 (1), 165-173, 2005 | 101 | 2005 |
| The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort J Guzman, K Oen, AM Huber, KW Duffy, G Boire, N Shiff, RA Berard, ... Annals of the rheumatic diseases 75 (6), 1092-1098, 2016 | 92 | 2016 |
| SB240563, a humanized anti-IL-5 monoclonal antibody. Initial single dose safety and activity in patients with asthma MJ Leckie Am J Respir Crit Care Med 159 (45), A624, 1999 | 81 | 1999 |
| Calcinosis is associated with digital ischaemia in systemic sclerosis—a longitudinal study M Baron, J Pope, D Robinson, N Jones, N Khalidi, P Docherty, ... Rheumatology 55 (12), 2148-2155, 2016 | 69 | 2016 |
| 2013 American College of Rheumatology/European League against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: data from the Canadian … H Alhajeri, M Hudson, M Fritzler, J Pope, S Tatibouet, J Markland, ... Arthritis care & research 67 (4), 582-587, 2015 | 67 | 2015 |
| The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohorts DH Dougherty, L Kwakkenbos, ME Carrier, G Salazar, S Assassi, M Baron, ... Rheumatology 57 (9), 1623-1631, 2018 | 65 | 2018 |
| Investigating the role of the interleukin-23/-17A axis in rheumatoid arthritis P Hillyer, MJ Larche, EP Bowman, TK McClanahan, R de Waal Malefyt, ... Rheumatology 48 (12), 1581-1589, 2009 | 65 | 2009 |
| Natural killer T cells in families of patients with systemic lupus erythematosus: their possible role in regulation of IGG production MRJ Green, ASM Kennell, MJ Larche, MH Seifert, DA Isenberg, ... Arthritis & Rheumatism 56 (1), 303-310, 2007 | 65 | 2007 |
Peter J BarnesImperial College LondonVerified email at imperial.ac.uk
